Novel therapeutic approach to primary biliary cirrhosis patients: Anti-eosinophil strategy

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1457-1461

  Miyaguchi, Shingo ^a   Oda, Masaya ^b   Saito, Hidetsugu ^b   Ishii, Hiromasa ^b  

^a Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Eosinophils; Pranlukast; Primary biliary cirrhosis

Indexed keywords

ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PRANLUKAST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE CLASSIFICATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LIVER BIOPSY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; CHROMONES; ENZYME TESTS; EOSINOPHILS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTE COUNT; LEUKOTRIENE ANTAGONISTS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED;

EID: 0031794312     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Terasaki S, Nakanuma Y, Yamazaki M Unoura M: Eosinophilic infiltration of the liver in primary biliary cirrhosis. A morphological study. Hepatology 1992; 17:206-211.
2. Miyaguchi S, Oda M, Mori M. et al: Immunohistochemical characterization of hepatic eosinphil cationic protein in primary biliary cirrhosis. Int Hepatol Comm 1996; 5:207-214.
3. Kobayashi S, Yoshida K, Mon A, et al: Inhibitory effect of ONO-1078, a novel leukotriene receptor antagonist, on human peripheral blood eosinophils. Japanese J Allergology 1996; 45:1166-1171 (in Japanese).
4. Underwood DC, Osborn RR, Newsholme SJ, Torphy TJ, Hay DW: Persistent airway eosinopbilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respiratory and Critical Care Medicine 1996; 154:850-857.
5. Nakagawa N, Obata T, Kobayashi T, Okada Y, et al: Effect of a peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. Eur J Pharma 1993; 235:211-219.
6. Mitchison HC, Bassendine MF, Malcolm AJ, Watson AJ, Reccord CO, James OFW: A pilot, double-blind, controlled 1-year trial of prednislone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. Hepatology 1989; 10:420-429.
7. Crowe J, Christtensen E, Smith M, et al: Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 1980; 78:1005-1010.
8. Minuk GY, Bohme CE, Burgess E, et al: Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Gastroenterology 1988; 322:1419-24.
9. Poupon RE, Balkau BB, Eschwege E, Roupon R: Multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Eng J Med 1990; 22:1548-1554.
10. Hoffman AF: Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease. In: Paumgartner G, Stiel A, Barbara L, Roda E, eds: Strategies for the treatment of hepatobiliary diseases. Kluwer Academic, Dordrecht, The Netherlands 1990; 13:333-335.
11. Yamazaki K, Nakadate I, Suzuku K, Sato S, Masuda T: Eosinophilia in Primary Biliary Cirrhosis. Am J Gastroenterol. 1996; 91:516-522.
12. Noguchi H, Kephart GM, Colby TY, et al: Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol. 1982; 140:521-529.